enGene Therapeutics Inc

NEW
NAS:ENGN (Canada)  
$ 1.7 +0.010 (+0.59%) 01:40 PM EST
At Loss
P/B:
0.45
Market Cap:
$ 113.88M
Enterprise V:
$ -111.23M
Volume:
339.69K
Avg Vol (2M):
911.26K
Trade In:
Volume:
339.69K
At Loss
Avg Vol (2M):
911.26K

enGene Therapeutics Inc (ENGN) Dividend

enGene Therapeutics Inc (ENGN) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -30.9%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ENGN Dividend

Does enGene Therapeutics Inc (ENGN) pay a dividend?

enGene Therapeutics Inc (ENGN) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't enGene Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. enGene Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -30.9% over the past 3 years.

What are dividend-paying alternatives to enGene Therapeutics Inc?

For dividend-paying alternatives in enGene Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.